IN2013CH00226A - - Google Patents

Download PDF

Info

Publication number
IN2013CH00226A
IN2013CH00226A IN226CH2013A IN2013CH00226A IN 2013CH00226 A IN2013CH00226 A IN 2013CH00226A IN 226CH2013 A IN226CH2013 A IN 226CH2013A IN 2013CH00226 A IN2013CH00226 A IN 2013CH00226A
Authority
IN
India
Application number
Inventor
Benny Antony
Original Assignee
Benny Antony
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benny Antony filed Critical Benny Antony
Priority to IN226CH2013 priority Critical patent/IN2013CH00226A/en
Priority to PCT/IN2014/000031 priority patent/WO2014111956A2/en
Priority to US14/800,950 priority patent/US10286027B2/en
Publication of IN2013CH00226A publication Critical patent/IN2013CH00226A/en
Priority to US15/478,013 priority patent/US20170202785A1/en
Priority to US16/171,117 priority patent/US20190060253A1/en
Priority to US17/002,568 priority patent/US12053438B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IN226CH2013 2005-05-30 2013-01-17 IN2013CH00226A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IN226CH2013 IN2013CH00226A (en) 2013-01-17 2013-01-17
PCT/IN2014/000031 WO2014111956A2 (en) 2013-01-17 2014-01-16 Sustained release formulations of curcuminoids and method of preparation thereof
US14/800,950 US10286027B2 (en) 2005-05-30 2015-07-16 Sustained release formulations of curcuminoids and method of preparation thereof
US15/478,013 US20170202785A1 (en) 2005-05-30 2017-04-03 Formulation of Curcumin with Enhanced Bioavailability of Curcumin and method of preparation and treatment thereof
US16/171,117 US20190060253A1 (en) 2005-05-30 2018-10-25 Formulation of Curcumin with Enhanced Bioavailability of Curcumin and method of preparation and treatment thereof
US17/002,568 US12053438B2 (en) 2005-05-30 2020-08-25 Formulation of curcuminoids with enhanced bioavailability of curcumin, demethoxycurcumin, bisdemethoxycurcumin and method of preparation and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN226CH2013 IN2013CH00226A (en) 2013-01-17 2013-01-17

Publications (1)

Publication Number Publication Date
IN2013CH00226A true IN2013CH00226A (en) 2015-08-07

Family

ID=51210161

Family Applications (1)

Application Number Title Priority Date Filing Date
IN226CH2013 IN2013CH00226A (en) 2005-05-30 2013-01-17

Country Status (2)

Country Link
IN (1) IN2013CH00226A (en)
WO (1) WO2014111956A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10363225B2 (en) * 2016-08-11 2019-07-30 Akay Flavours & Aromatics Pvt, Ltd Non-bleeding bioactive natural pigments which prevent color and dust explosions, method of preparation thereof
EP3870201A4 (en) * 2018-10-23 2022-08-03 Stabicon Life Sciences Pvt. Ltd. Formulation comprising water soluble particles of a non-curcuminoid and a curcuminoid
CA3145084A1 (en) * 2019-06-11 2020-12-17 Olene Life Sciences Private Limited Bioavailable turmeric composition and process for preparation thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2654566A1 (en) * 2006-06-09 2007-12-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
WO2011082290A2 (en) * 2009-12-31 2011-07-07 Organomed Corporation Formulations from natural products, turmeric, and aspirin
ES2657364T3 (en) * 2010-04-05 2018-03-05 Benny Antony Formulation of curcumin with an improved bioavailability of curcumin and method of preparation and treatment thereof
WO2012023146A1 (en) * 2010-08-16 2012-02-23 Benny Antony A pharmaceutical composition of reformulated turmeric extract and a method thereof
US20140039031A1 (en) * 2011-02-23 2014-02-06 Dispersol Technologies. LLC Pharmaceutical formulations of acetyl-11-keto-b-boswellic acid, diindolylmethane, and curcumin for pharmaceutical applications

Also Published As

Publication number Publication date
WO2014111956A2 (en) 2014-07-24
WO2014111956A3 (en) 2014-12-04

Similar Documents

Publication Publication Date Title
BR112015007533A2 (en)
BR112014018502A2 (en)
BR112014019326A2 (en)
BR112014018516A2 (en)
BR112014020341A2 (en)
BR112014018480A2 (en)
BR112016013983A2 (en)
BR112014021878A2 (en)
BR112016001608A2 (en)
BR112014018468A2 (en)
BR112014017901A2 (en)
BR112015018036A2 (en)
BR112015026283A2 (en)
BR112014018207A2 (en)
BR112014019204A2 (en)
BR112015015948A2 (en)
BR112016010983A2 (en)
BR112014018578A2 (en)
BR112014018483A2 (en)
BR112014017653A2 (en)
BR112015015312A2 (en)
BR112014018353A2 (en)
BR112016000925A2 (en)
BR112014018496A2 (en)
BR112014024039A2 (en)